Ashwagandha

Ashwagandha 10:1 extract

Products
2
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 2 labeled products
Min
7.5 mg
Typical
7.5 mg
Max
7.5 mg
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Top brands carrying Ashwagandha 10:1 extract

15 brands rolled up

Products containing Ashwagandha 10:1 extract

2 in catalog